ADLM Calls on Feds to Regulate AI in the Clinical Lab Sector
But anti-regulatory stance taken by Trump administration could serve as a potential obstacle in the effort
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
But anti-regulatory stance taken by Trump administration could serve as a potential obstacle in the effort
From - Laboratory Industry Report
Deal volume in May and June was noticeably higher, especially in terms of M&A activity. There was more global activity over the current than…
From - G2 Compliance Advisor
The OIG Model Compliance Plan for Clinical Laboratories requires labs to establish mechanisms for not only receiving but promptly investigating…
From - National Intelligence Report
The U.S. Food and Drug Administration (FDA) has been chronically plagued with understaffing, an ever expanding workload and…
From - National Intelligence Report
The feds arrested a cardiologist, neurologist and four others for their role in an elaborate fraud scheme…
From - National Intelligence Report
False Claims Act actions targeting health care vendors have become more common. eClinicalWorks (ECW), one country's biggest…
By William A. Schiemann, Ph.D bio
Most leaders of companies today recognize the importance of having engaged people at work. Yet research from the Metrus Institute, Gallup, and others say that…